
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
Departments of Pediatrics [R. G., R. S., M. D., E. C., L. H. W., P. A. M.], Nuclear Medicine [A. C. L., S. D. Y., S. M. L.], Pathology [C. A., A. G. H.], Radiology [D. P.], and Surgery, Orthopaedic Service [J. H. H.], Memorial Sloan-Kettering Cancer Center, New York, New York 10021
In osteosarcoma, some studies have suggested P-glycoprotein expression is a prognostic factor. The clearance of 99mtechnetium hexakis-2-methoxyisobutylisonitrile (99mTc-MIBI) has been used in some tumor systems as an in vivo measure of P-glycoprotein-mediated efflux. In this study we explored the correlation between 99mTc-MIBI clearance and histological necrosis following induction chemotherapy and P-glycoprotein expression in osteosarcoma. The primary tumors of 20 patients with high-grade osteosarcoma were imaged at diagnosis with 99mTc-MIBI, and the uptake ratios and biological half-lives were calculated. P-Glycoprotein expression in the tumor tissue was determined immunohistochemically and by measuring mRNA expression of the multidrug resistance-1 gene. The histological necrosis following induction chemotherapy was assessed by the Huvos grading system. The biological half-life of 99mTc-MIBI ranged from 1.4 to 52.5 h. Seven of the 20 tumor samples had a favorable extent of necrosis following induction chemotherapy. The 99mTc-MIBI half-life and uptake ratio showed no correlation with histological necrosis following induction chemotherapy. The 99mTc-MIBI half-life and uptake ratio did not correlate with either measure of P-glycoprotein expression. The results of this pilot study indicate that 99mTc-MIBI imaging is not an effective predictor of histological necrosis following induction chemotherapy in high-grade osteosarcoma. 99mTc-MIBI imaging did not correlate with measures of P-glycoprotein expression in the tumor tissue.
This article has been cited by other articles:
![]() |
K. Kawata, M. Kanai, T. Sasada, S. Iwata, N. Yamamoto, and A. Takabayashi Usefulness of 99mTc-Sestamibi Scintigraphy in Suggesting the Therapeutic Effect of Chemotherapy against Gastric Cancer Clin. Cancer Res., June 1, 2004; 10(11): 3788 - 3793. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |